Banner Image

Test Directory

Hu, Yo, and Ri Antibodies with Reflex to Titers and Western Blot

Test Summary

Hu anti-neuronal nuclear antibody (anti-Hu) is found in 5-10% of patients with small cell carcinoma of the lung. Purkinje cell (Yo) antibody is found in patients with paraneoplastic cerebellar degeneration and is associated with breast, ovarian, and other gynecologic cancers. Some patients with ovarian cancer have low titers of Yo antibodies in the absence of cerebellar degeneration. Anti-Hu antibodies are associated with paraneoplastic encephalomyelitis and sensory neuropathy. Anti-Ri antibody can be detected in patients with paraneoplastic opsoclonus/myoclonus syndrome. Neoplasms most often associated with anti-Ri include breast cancer, small cell lung cancer, and gynecological cancers.

Aliases

  • Paraneoplastic Syndrome AB Panel

Specimen Collection

Special Instructions

N/A

Preferred Specimen

1.5 mL serum

Minimum Volume

0.6 mL

Instructions

N/A

Patient Preparation

Overnight fasting is preferred

Storage

Transport tube

Transport Temperature

Room temperature

Specimen Stability

  • Room temperature: 7 days
  • Refrigerated: 14 days
  • Frozen: 21 days

Limitations

N/A

Other Acceptable Specimens

N/A

Unacceptable Specimens

N/A

Order Code

NEURAB

EPIC (Premier) Code

LAB5509

Includes

Neuronal Nuclear (Hu) Antibody with Reflex to Titer and Western Blot; Neuronal Nuclear (Yo) Antibody with Reflex to Titer and Western Blot; Neuronal Nuclear (Ri) Antibody with Reflex to Titer and Western Blot

If Hu Antibody Screen, IFA is positive, Hu Antibody, Western Blot will be performed at an additional charge (CPT code(s): 84181).
If Hu Antibody, Western Blot is positive, Hu Antibody, Titer will be performed at an additional charge (CPT code(s): 86256).
If Yo Antibody Screen, IFA is positive, Yo Antibody, Western Blot will be performed at an additional charge (CPT code(s): 84181).
If Yo Antibody, Western Blot is positive, Yo Antibody, Titer will be performed at an additional charge (CPT code(s): 86256).
If Ri Antibody Screen, IFA is positive, Ri Antibody, Western Blot will be performed at an additional charge (CPT code(s): 84181).
If Ri Antibody, Western Blot is positive, Ri Antibody, Titer will be performed at an additional charge (CPT code(s): 86256).

CPT Code

  • 86255 (x3)

Billing Code

  • 670349

CPT Statement

Methodology

Immunofluorescence Assay (IFA)

FDA Status

This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics. It has not been cleared or approved by the U.S. Food and Drug Administration. The FDA has determined that such clearance or approval is not necessary. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes.

Physician Attestation of Informed Consent

N/A

Testing Laboratory

Quest Diagnostics Nichols Institute
33608 Ortega Highway
San Juan Capistrano CA, 92675

Department

Reference Testing

Reference Range

See Laboratory Report

Setup Schedule / Expected Turnaround Time

Monday, Wednesday, Friday; Report available: 3 days

Specimen Collection

Special Instructions

N/A

Preferred Specimen

1.5 mL serum

Minimum Volume

0.6 mL

Instructions

N/A

Patient Preparation

Overnight fasting is preferred

Storage

Transport tube

Transport Temperature

Room temperature

Specimen Stability

  • Room temperature: 7 days
  • Refrigerated: 14 days
  • Frozen: 21 days

Limitations

N/A

Other Acceptable Specimens

N/A

Unacceptable Specimens

N/A

Billing

CPT Code

  • 86255 (x3)

Billing Code

  • 670349

CPT Statement

Result Information

Methodology

Immunofluorescence Assay (IFA)

Testing Laboratory

N/A

Reference Range

See Laboratory Report

Setup Schedule / Expected Turnaround Time

Monday, Wednesday, Friday; Report available: 3 days